Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale P Conner

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The AAPS Journal|May 21, 2013
Bioequivalence for locally acting nasal spray and nasal aerosol products: standard development and generic approvalBing V Li, Feiyan Jin, Sau L Lee, et al.
Dermatologic Therapy|May 21, 2009
Generic drugs--safe, effective, and affordableJohn R Peters, Dena R Hixon, Dale P Conner, et al.
The AAPS Journal|June 5, 2009
In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseasesSau Lawrence Lee, Wallace P Adams, Bing V Li, et al.
International Journal of Pharmaceutics|August 2, 2011
The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluationWenlei Jiang, Stephanie Kim, Xinyuan Zhang, et al.
The Annals of Pharmacotherapy|September 25, 2009
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug AdministrationBarbara M Davit, Patrick E Nwakama, Gary J Buehler, et al.
The AAPS Journal|June 22, 2012
Statistics on BCS classification of generic drug products approved between 2000 and 2011 in the USAAnil K Nair, Om Anand, Nam Chun, et al.
The AAPS Journal|September 8, 2017
In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube AdministrationPing Ren, Minglei Cui, Om Anand, et al.
The AAPS Journal|December 2, 2011
Common deficiencies with bioequivalence submissions in abbreviated new drug applications assessed by FDAQing Liu, Barbara M Davit, Svetlana A Cherstniakova, et al.
The AAPS Journal|May 1, 2008
Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applicationsBarbara M Davit, Dale P Conner, Beth Fabian-Fritsch, et al.
Molecular Pharmaceutics|July 20, 2005
The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugsLawrence X Yu, Arthur B Straughn, Patrick J Faustino, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The AAPS Journal|May 21, 2013
Bioequivalence for locally acting nasal spray and nasal aerosol products: standard development and generic approvalBing V Li, Feiyan Jin, Sau L Lee, et al.
Dermatologic Therapy|May 21, 2009
Generic drugs--safe, effective, and affordableJohn R Peters, Dena R Hixon, Dale P Conner, et al.
The AAPS Journal|June 5, 2009
In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseasesSau Lawrence Lee, Wallace P Adams, Bing V Li, et al.
International Journal of Pharmaceutics|August 2, 2011
The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluationWenlei Jiang, Stephanie Kim, Xinyuan Zhang, et al.
The Annals of Pharmacotherapy|September 25, 2009
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug AdministrationBarbara M Davit, Patrick E Nwakama, Gary J Buehler, et al.
The AAPS Journal|June 22, 2012
Statistics on BCS classification of generic drug products approved between 2000 and 2011 in the USAAnil K Nair, Om Anand, Nam Chun, et al.
The AAPS Journal|September 8, 2017
In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube AdministrationPing Ren, Minglei Cui, Om Anand, et al.
The AAPS Journal|December 2, 2011
Common deficiencies with bioequivalence submissions in abbreviated new drug applications assessed by FDAQing Liu, Barbara M Davit, Svetlana A Cherstniakova, et al.
The AAPS Journal|May 1, 2008
Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applicationsBarbara M Davit, Dale P Conner, Beth Fabian-Fritsch, et al.
Molecular Pharmaceutics|July 20, 2005
The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugsLawrence X Yu, Arthur B Straughn, Patrick J Faustino, et al.
Pageof 3